Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS
· Delayed Price · Currency is USD
26.20
+0.39 (1.53%)
At close: Mar 17, 2025
Hikma Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 5,856 | 5,533 | 5,038 | 4,118 | 6,954 | 7,923 | Upgrade
|
| Market Cap Growth | 9.82% | 9.82% | 22.33% | -40.78% | -12.23% | 24.01% | Upgrade
|
| Enterprise Value | 7,028 | 6,553 | 6,071 | 5,281 | 7,541 | 8,475 | Upgrade
|
| Last Close Price | 25.72 | 23.68 | 22.09 | 18.30 | 27.77 | 33.34 | Upgrade
|
| PE Ratio | 16.31 | 15.41 | 26.52 | 21.91 | 16.52 | 18.38 | Upgrade
|
| PS Ratio | 1.87 | 1.77 | 1.75 | 1.64 | 2.72 | 3.38 | Upgrade
|
| PB Ratio | 2.52 | 2.38 | 2.28 | 1.92 | 2.82 | 3.69 | Upgrade
|
| P/TBV Ratio | 5.07 | 4.79 | 4.59 | 4.07 | 4.46 | 6.29 | Upgrade
|
| P/FCF Ratio | 14.68 | 13.87 | 11.48 | 10.51 | 14.11 | 27.13 | Upgrade
|
| P/OCF Ratio | 10.38 | 9.81 | 8.29 | 7.77 | 10.90 | 17.08 | Upgrade
|
| EV/Sales Ratio | 2.12 | 2.10 | 2.11 | 2.10 | 2.95 | 3.62 | Upgrade
|
| EV/EBITDA Ratio | 8.30 | 8.33 | 7.62 | 7.88 | 10.50 | 12.96 | Upgrade
|
| EV/EBIT Ratio | 10.87 | 10.78 | 9.71 | 10.61 | 13.44 | 15.70 | Upgrade
|
| EV/FCF Ratio | 17.61 | 16.42 | 13.83 | 13.47 | 15.30 | 29.03 | Upgrade
|
| Debt / Equity Ratio | 0.56 | 0.56 | 0.54 | 0.60 | 0.34 | 0.43 | Upgrade
|
| Debt / EBITDA Ratio | 1.64 | 1.64 | 1.46 | 1.88 | 1.16 | 1.40 | Upgrade
|
| Debt / FCF Ratio | 3.27 | 3.27 | 2.71 | 3.27 | 1.72 | 3.19 | Upgrade
|
| Asset Turnover | 0.64 | 0.64 | 0.63 | 0.57 | 0.60 | 0.58 | Upgrade
|
| Inventory Turnover | 1.82 | 1.82 | 1.76 | 1.70 | 1.73 | 1.70 | Upgrade
|
| Quick Ratio | 0.60 | 0.60 | 0.82 | 1.05 | 1.31 | 1.05 | Upgrade
|
| Current Ratio | 1.14 | 1.14 | 1.57 | 1.86 | 2.06 | 1.87 | Upgrade
|
| Return on Equity (ROE) | 15.98% | 15.98% | 8.81% | 8.28% | 18.20% | 20.11% | Upgrade
|
| Return on Assets (ROA) | 7.75% | 7.75% | 8.54% | 7.04% | 8.24% | 8.37% | Upgrade
|
| Return on Capital (ROIC) | 10.81% | 10.81% | 11.44% | 9.23% | 10.97% | 11.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.30% | 19.30% | 18.70% | 14.70% | 16.70% | 17.40% | Upgrade
|
| Earnings Yield | 6.13% | 6.49% | 3.77% | 4.57% | 6.05% | 5.44% | Upgrade
|
| FCF Yield | 6.81% | 7.21% | 8.71% | 9.52% | 7.09% | 3.69% | Upgrade
|
| Dividend Yield | 3.05% | 3.38% | 3.26% | 3.06% | 1.94% | 1.50% | Upgrade
|
| Payout Ratio | 48.75% | 48.75% | 72.10% | 66.49% | 28.50% | 25.29% | Upgrade
|
| Buyback Yield / Dilution | -0.51% | -0.51% | 1.13% | 3.47% | 2.10% | 2.06% | Upgrade
|
| Total Shareholder Return | 2.55% | 2.87% | 4.39% | 6.53% | 4.05% | 3.56% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.